{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:25:05Z","timestamp":1764782705735,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1995,8,1]],"date-time":"1995-08-01T00:00:00Z","timestamp":807235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[1995,8]]},"DOI":"10.1016\/0091-3057(95)00095-e","type":"journal-article","created":{"date-parts":[[2003,5,19]],"date-time":"2003-05-19T19:16:47Z","timestamp":1053371807000},"page":"565-569","source":"Crossref","is-referenced-by-count":18,"title":["Dopamine D2 receptors: A potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments"],"prefix":"10.1016","volume":"51","author":[{"given":"K.F.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Heal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0091-3057(95)00095-E_BIB1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","article-title":"The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action","volume":"166","author":"Andersen","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/278464a0","article-title":"Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain","volume":"278","author":"Bergstrom","year":"1979","journal-title":"Nature"},{"key":"10.1016\/0091-3057(95)00095-E_BIB3","first-page":"2P","article-title":"Dopamine D1 and D2 receptor binding sites in depressed suicide victims","volume":"111","author":"Bowden","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.2042-7158.1977.tb11370.x","article-title":"Biochemical differentiation of amphetamine vs. methylphenidate and nomifensine in rats","volume":"29","author":"Braestrup","year":"1977","journal-title":"J. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1471-4159.1991.tb03802.x","article-title":"Interstitial 3-methoxytyramine reflects striatal dopamine release: An in vivo microdialysis study","volume":"57","author":"Brown","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/0091-3057(95)00095-E_BIB6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","article-title":"Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain","volume":"196","author":"Burt","year":"1977","journal-title":"Science"},{"key":"10.1016\/0091-3057(95)00095-E_BIB7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1192\/bjp.115.529.1367","article-title":"Tryptophan pyrrolase \u2014 A biochemical factor in depressive illness","volume":"115","author":"Curzon","year":"1969","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/0091-3057(95)00095-E_BIB8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0091-3057(82)90478-6","article-title":"Dopaminergic properties of nomifensine","volume":"17","author":"Gianutsos","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/0091-3057(95)00095-E_BIB9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0024-3205(89)90550-X","article-title":"Chronic electroconvulsive shock and neurotransmitter receptors. An update","volume":"44","author":"Gleiter","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/0091-3057(95)00095-E_BIB10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0028-3908(90)90038-S","article-title":"A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain","volume":"29","author":"Heal","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/0091-3057(95)00095-E_BIB11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02245152","article-title":"A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: Evidence that dopamine is not a pharmacological target for sibutramine","volume":"107","author":"Heal","year":"1992","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/0091-3057(95)00095-E_BIB12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02244212","article-title":"Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic \u03b12-adrenoceptor function in the brain: Rapid down-regulation by sibutramine hydrochloride","volume":"103","author":"Heal","year":"1991","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/0091-3057(95)00095-E_BIB13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"227","author":"Kebabian","year":"1979","journal-title":"Nature"},{"key":"10.1016\/0091-3057(95)00095-E_BIB14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(87)90248-2","article-title":"Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system","volume":"139","author":"Klimek","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB15","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/0006-2952(85)90778-6","article-title":"Specific in vitro and in vivo binding of [3H]raclopride. A potent substituted benzamide drug with high affinity for dopamine D2 receptors in the rat brain","volume":"34","author":"K\u00f6hler","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(69)91140-4","article-title":"Intensification of central serotonergic processes as a possible determinant of thymoleptic effort","volume":"i","author":"Lapin","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/0091-3057(95)00095-E_BIB17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(82)90188-1","article-title":"Electroconvulsive shock prevents dopamine receptor supersensitivity","volume":"80","author":"Lerer","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0028-3908(87)90031-1","article-title":"Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol","volume":"26","author":"Liskowsky","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/0091-3057(95)00095-E_BIB19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/0091-3057(95)00095-E_BIB20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01244989","article-title":"The influence of repeated treatment with imipramine, (+)- and (\u2212)-oxaprotiline on behavioural effects of dopamine D1 and D2 agonists","volume":"76","author":"Maj","year":"1989","journal-title":"J. Neural Transm."},{"key":"10.1016\/0091-3057(95)00095-E_BIB21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01249099","article-title":"Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine","volume":"60","author":"Maj","year":"1984","journal-title":"J. Neural Transm."},{"key":"10.1016\/0091-3057(95)00095-E_BIB22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.2042-7158.1985.tb05085.x","article-title":"Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens","volume":"37","author":"Maj","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB23","first-page":"405P","article-title":"Sodium dependent binding of [3H]raclopride to rat striatal membranes","volume":"100","author":"Martin","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(80)90515-1","article-title":"LIGAND: A versatile computerized approach for characterization of ligand-binding systems","volume":"107","author":"Munson","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/0091-3057(95)00095-E_BIB25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0028-3908(89)90168-8","article-title":"Effects of chronic electroconvulsive shock on D1 and D2 dopamine receptor-mediated activity of adenylate cyclase in homogenates of striatum and limbic forebrain of rat","volume":"28","author":"Newman","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/0091-3057(95)00095-E_BIB26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.6251550","article-title":"Chronic antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding","volume":"210","author":"Peroutka","year":"1980","journal-title":"Science"},{"key":"10.1016\/0091-3057(95)00095-E_BIB27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/clpt.1987.15","article-title":"Noradrenergic and dopaminergic effects of nomifensine in healthy volunteers","volume":"40","author":"Scheinin","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/0091-3057(95)00095-E_BIB28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1126\/science.156.3771.21","article-title":"Biogenic amines and emotion","volume":"156","author":"Schildkraut","year":"1967","journal-title":"Science"},{"key":"10.1016\/0091-3057(95)00095-E_BIB29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology","volume":"15","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/0091-3057(95)00095-E_BIB30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF02245799","article-title":"Repeated ECS enhances dopamine D1 but not D2 agonist-induced behavioural responses in rats","volume":"100","author":"Sharp","year":"1990","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/0091-3057(95)00095-E_BIB31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(81)90531-8","article-title":"Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine","volume":"74","author":"Spyraki","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB32","series-title":"Receptor biochemistry and methodology","first-page":"29","article-title":"Isolation and characterisation of dopamine receptors","volume":"vol. 8","author":"Strange","year":"1987"},{"key":"10.1016\/0091-3057(95)00095-E_BIB33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(87)90603-0","article-title":"Dopamine reuptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat","volume":"135","author":"Westerink","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/0091-3057(95)00095-E_BIB34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-0173(83)90007-3","article-title":"Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments","volume":"6","author":"Willner","year":"1983","journal-title":"Brain Res. Rev."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:009130579500095E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:009130579500095E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T18:22:47Z","timestamp":1620325367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/009130579500095E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["009130579500095E"],"URL":"https:\/\/doi.org\/10.1016\/0091-3057(95)00095-e","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}